Free Trial
NYSEAMERICAN:CCEL

Cryo-Cell International (CCEL) Stock Price, News & Analysis

Cryo-Cell International logo
$4.70 -0.05 (-1.05%)
Closing price 08/29/2025 04:10 PM Eastern
Extended Trading
$4.72 +0.02 (+0.43%)
As of 08/29/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cryo-Cell International Stock (NYSEAMERICAN:CCEL)

Key Stats

Today's Range
$4.67
$4.77
50-Day Range
$4.11
$5.43
52-Week Range
$4.09
$9.43
Volume
9,485 shs
Average Volume
17,126 shs
Market Capitalization
$37.88 million
P/E Ratio
N/A
Dividend Yield
12.77%
Price Target
$8.50
Consensus Rating
Buy

Company Overview

Cryo-Cell International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

CCEL MarketRank™: 

Cryo-Cell International scored higher than 70% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cryo-Cell International is -156.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cryo-Cell International is -156.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    0.28% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 34.15%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Cryo-Cell International is a leading dividend payer. It pays a dividend yield of 12.77%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Cryo-Cell International does not have a long track record of dividend growth.

  • Read more about Cryo-Cell International's dividend.
  • Percentage of Shares Shorted

    0.28% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 34.15%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cryo-Cell International has a news sentiment score of 1.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Cryo-Cell International this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    1 people have added Cryo-Cell International to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cryo-Cell International insiders have bought more of their company's stock than they have sold. Specifically, they have bought $285,561.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    36.86% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 10.44% of the stock of Cryo-Cell International is held by institutions.

  • Read more about Cryo-Cell International's insider trading history.
Receive CCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CCEL Stock News Headlines

This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
Cryo-Cell International, Inc. Provides Dividend Update
CCEL Cryo-Cell International, Inc. - Seeking Alpha
See More Headlines

CCEL Stock Analysis - Frequently Asked Questions

Cryo-Cell International's stock was trading at $6.50 at the beginning of the year. Since then, CCEL shares have decreased by 27.7% and is now trading at $4.70.

Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) released its quarterly earnings data on Tuesday, October, 15th. The company reported $0.13 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.11. The business earned $8.07 million during the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 1.07% and a negative net margin of 0.53%.

Cryo-Cell International's top institutional shareholders include Topline Capital Management LLC (0.50%).
View institutional ownership trends
.

Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Crescent Biopharma (CBIO), iClick Interactive Asia Group (ICLK), NVIDIA (NVDA), AcelRx Pharmaceuticals (ACRX) and Aspen Group (ASPU).

Company Calendar

Last Earnings
10/15/2024
Today
8/31/2025
Fiscal Year End
11/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSEAMERICAN:CCEL
CIK
862692
Employees
90
Year Founded
1989

Price Target and Rating

High Price Target
$8.50
Low Price Target
$8.50
Potential Upside/Downside
+80.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$400 thousand
Net Margins
-0.53%
Pretax Margin
5.15%
Return on Equity
-1.07%
Return on Assets
-0.27%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.60
Quick Ratio
0.57

Sales & Book Value

Annual Sales
$31.99 million
Price / Sales
1.18
Cash Flow
$0.18 per share
Price / Cash Flow
26.22
Book Value
($1.64) per share
Price / Book
-2.87

Miscellaneous

Outstanding Shares
8,060,000
Free Float
5,087,000
Market Cap
$37.88 million
Optionable
Not Optionable
Beta
0.64

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSEAMERICAN:CCEL) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners